| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Revenue | $13.35B | +3.9% |
| R&D Expense | $3.32B | +8.5% |
| SG&A Expense | $1.13B | +5.8% |
| Operating Income | $2.02B | -15.3% |
| Interest Expense | $304.0M | +20.6% |
| Pre-tax Income | $1.79B | -14.1% |
| Income Tax | $478.0M | +80.4% |
| Net Income | $1.31B | -27.8% |
| EPS (Basic) | $3.11 | -28.3% |
| EPS (Diluted) | $3.09 | -28.3% |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.10B | +41.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $2.51B | +9.3% |
| Current Assets | $10.23B | +28.4% |
| Total Assets | $31.24B | +8.9% |
| Current Liabilities | $12.39B | +28.4% |
| Long-term Debt | $9.44B | -25.5% |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.30B | -1.3% |
| Capital Expenditures | $450.0M | +16.6% |
| Investing Cash Flow | -$367.0M | -11.6% |
| Financing Cash Flow | -$2.47B | +51.9% |
| Free Cash Flow | $3.85B | -3.0% |
| Total Liabilities |
| $29.70B |
| +0.5% |
| Stockholders' Equity | $1.53B | +275.1% |